This has been an ongoing problem for several years now. At times is seems to be getting better and then it is scarce again. Here is the latest from the FDA
BCG Live (Intravesical)
TICE® BCG
NDC Number:
00052-0602-02
50 mg lyophilized powder Organon Teknika, Corporation LLC, a subsidiary of Merck & Co, Inc.
For questions, please call customer service at: 1-800-NSC-MERCK
(1-800-672-6372) TICE® BCG, BCG Live (Intravesical) is currently available.
In order to help manage inventory and to minimize disruption to patient care when demand exceeds production plans and available inventory product will be placed on allocation. Demand increase in the drug or biological product Because of increased global demand and as the only source of BCG Live (Intravesical) in the United States and many other countries, Merck anticipates supply constraints for TICE® BCG for the foreseeable future.
To minimize disruption to patient care and address the current imbalance between supply and increased global demand TICE® BCG will be under allocation when demand exceeds production plans and available inventory.
For questions, please call Merck customer service at:
1-800-NSC-MERCK
(1-800-672-6372)
Or visit
www.merck.com/product/
oncology/home.htmlExternal Link Disclaimer Onset:January 2019
Updated: December 2019
Ongoing